Serum Anti-Tissue Transglutaminase IgG at Chughtai Lab

Serum Anti-Tissue Transglutaminase IgG at Chughtai Lab

The Serum Anti-Tissue Transglutaminase IgG (anti-tTG IgG) test is a highly specialized serological assay used primarily in the diagnostic evaluation of celiac disease, an autoimmune enteropathy triggered by the ingestion of dietary gluten. Tissue transglutaminase is a multifunctional enzyme located in the subepithelial space of the small intestine. In individuals with a genetic predisposition (specifically carrying human leukocyte antigen HLA-DQ2 or HLA-DQ8 alleles), the ingestion of gluten leads to the deamidation of gliadin peptides by tTG. This modification creates highly immunogenic epitopes that stimulate an abnormal T-cell mediated immune response, resulting in chronic mucosal inflammation, villous atrophy, and crypt hyperplasia in the small intestine.

While the anti-tTG IgA antibody is the primary screening tool recommended by international gastroenterology guidelines due to its high sensitivity and specificity, the anti-tTG IgG antibody plays an indispensable clinical role. Approximately 2% to 3% of patients with celiac disease suffer from selective immunoglobulin A (IgA) deficiency, a condition that is ten to fifteen times more common in celiac patients than in the general population. In these individuals, IgA-based serological tests will yield false-negative results despite active disease. Therefore, the anti-tTG IgG test is utilized as a secondary screening marker or as part of a comprehensive celiac serology panel to ensure diagnostic accuracy in patients with low or absent total serum IgA levels.

At Chughtai Lab, Pakistan’s premier diagnostic network, this test is performed using advanced immunological methodologies such as Enzyme-Linked Immunosorbent Assay (ELISA) or Chemiluminescent Immunoassay (CLIA). These state-of-the-art technologies allow for the precise quantitative measurement of IgG autoantibodies directed against recombinant human tTG. By providing highly reproducible and accurate quantitative values, Chughtai Lab assists gastroenterologists, pediatricians, and general physicians across Pakistan in establishing a definitive diagnosis, monitoring dietary compliance, and preventing long-term complications associated with untreated gluten-sensitive enteropathy.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical for the clinical validity of the Serum Anti-Tissue Transglutaminase IgG test. Because this test measures the immune system’s response to gluten, the patient must maintain a gluten-containing diet prior to sample collection. The following guidelines should be strictly observed:

• Maintain a Gluten-Containing Diet: The patient must consume gluten-containing foods (such as wheat bread, pasta, barley, and rye) daily for at least 6 to 8 weeks before the test. Initiating a gluten-free diet (GFD) prior to testing can lead to a rapid decline in circulating antibody levels, resulting in a false-negative result.
• Fasting Requirements: Routine fasting is generally not required for this specific immunological assay. However, patients should follow any concurrent fasting instructions if other blood tests (such as a lipid profile or fasting blood glucose) are scheduled on the same day.
• Medication Review: Patients must inform their healthcare provider of all medications, particularly immunosuppressants, systemic corticosteroids, or chemotherapy agents, as these can suppress antibody production and alter test results.
• Hydration: Adequate hydration is recommended to facilitate ease of venipuncture.

During the Procedure

The Serum Anti-Tissue Transglutaminase IgG test is a standard venipuncture procedure performed by highly trained phlebotomists at Chughtai Lab collection centers. The process is quick, safe, and minimally invasive:

• Patient Positioning: The patient is seated comfortably, and the preferred arm is extended and supported.
• Site Selection and Cleansing: The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa. The skin over the site is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry.
• Tourniquet Application: A sterile tourniquet is applied a few inches above the selected site to transiently restrict venous blood flow, making the vein more prominent.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a serum separator tube or red-top tube) is inserted gently into the vein.
• Sample Collection: The required volume of blood (usually 3 to 5 mL) is drawn into the tube. Once the collection is complete, the tourniquet is released, and the needle is smoothly withdrawn.
• Post-Puncture Care: Gentle pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis, followed by the application of an adhesive bandage.
• Safety and Comfort: The entire process takes less than five minutes. Patients may experience a mild, transient pinching sensation during needle insertion. Serious complications, such as hematoma or infection, are extremely rare.

When is a Serum Anti-Tissue Transglutaminase IgG Performed?

Suspected Celiac Disease with IgA Deficiency

Physicians request the anti-tTG IgG test when a patient exhibits classic symptoms of celiac disease but has been diagnosed with selective IgA deficiency, or when initial IgA-based screening tests return unexpectedly low or borderline values. Measuring the IgG subclass of these autoantibodies bypasses the diagnostic blind spot created by IgA deficiency, ensuring that celiac disease is not missed in vulnerable patient populations.

Chronic Gastrointestinal Symptoms

This test is indicated for patients presenting with persistent, unexplained gastrointestinal distress. Common clinical presentations include chronic or intermittent diarrhea, abdominal pain, cramping, bloating, flatulence, and steatorrhea (foul-smelling, fatty stools). These symptoms arise from the progressive destruction of the small intestinal villi, which severely compromises the mucosal surface area available for nutrient absorption.

Unexplained Extraintestinal Manifestations

Celiac disease frequently presents with non-gastrointestinal or systemic symptoms. Physicians order the anti-tTG IgG test to investigate unexplained iron-deficiency anemia that is refractory to oral iron supplementation, chronic fatigue, unexplained weight loss, recurrent aphthous stomatitis (mouth ulcers), elevated liver transaminases, premature osteoporosis, and neurological symptoms such as peripheral neuropathy or ataxia.

Screening High-Risk and Genetically Predisposed Populations

Asymptomatic individuals who belong to high-risk groups are routinely screened using this assay. This includes first-degree relatives of patients with confirmed celiac disease, as well as individuals diagnosed with associated autoimmune conditions such as Type 1 Diabetes Mellitus, Hashimoto’s thyroiditis, autoimmune hepatitis, Down syndrome, Turner syndrome, and Williams syndrome.

Pediatric Growth Failure and Failure to Thrive

In pediatric patients, chronic malabsorption due to gluten-sensitive enteropathy can manifest as failure to thrive, short stature, delayed puberty, dental enamel defects, and irritability. Pediatricians utilize the anti-tTG IgG test as a non-invasive, highly reliable screening tool to identify celiac disease early, allowing for timely dietary intervention and the prevention of permanent developmental delays.

What Does a Serum Anti-Tissue Transglutaminase IgG Detect?

The quantitative measurement of Serum Anti-Tissue Transglutaminase IgG provides critical clinical insights into the immunological activity of gluten-sensitive enteropathy. The assay is designed to detect and quantify the following clinical states and findings:

• Active Celiac Disease: Markedly elevated levels of anti-tTG IgG in a patient consuming a gluten-containing diet strongly suggest active celiac disease, particularly in the context of IgA deficiency.
• Selective IgA Deficiency: When paired with a total serum IgA test, a positive anti-tTG IgG confirms that the patient’s celiac-related immune response is mediated via the IgG pathway due to an underlying lack of secretory IgA.
• Gluten-Free Diet Compliance: A gradual decline in anti-tTG IgG levels over several months in a patient previously diagnosed with celiac disease indicates successful adherence to a gluten-free diet and subsequent mucosal healing.
• Dietary Non-Compliance or Accidental Gluten Exposure: Persistently high or rising levels of anti-tTG IgG in a patient supposedly on a gluten-free diet indicate ongoing, intentional, or accidental exposure to gluten.
• Dermatitis Herpetiformis: Elevated anti-tTG IgG levels can support the diagnosis of dermatitis herpetiformis, an intensely itchy, blistering skin manifestation of gluten sensitivity.
• Borderline or Equivocal Autoantibody Levels: Mildly elevated levels that require clinical correlation, potential HLA genetic testing, or a follow-up small bowel biopsy to confirm or rule out early-stage or latent celiac disease.
• Seronegative Celiac Disease: A small percentage of celiac patients may test negative for anti-tTG IgG despite having biopsy-proven enteropathy, highlighting the need for comprehensive clinical evaluation.
• False-Negative Results due to Dietary Restriction: Normal or undetectable levels of anti-tTG IgG in a patient who has already self-initiated a gluten-free diet, mask the underlying disease.
• Immunosuppression-Induced Low Antibody Levels: Reduced antibody titers in patients taking immunosuppressive therapies, which can mask active autoimmune enteropathy.
• Autoimmune Cross-Reactivity: Occasional low-level positive results in patients with other autoimmune disorders, such as rheumatoid arthritis or systemic lupus erythematosus, which must be carefully differentiated from true celiac disease.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, accurate, and highly accessible diagnostic reporting services across Pakistan. The Serum Anti-Tissue Transglutaminase IgG test is processed in our centralized, state-of-the-art immunology department using automated analyzers that undergo rigorous daily quality control protocols.

The typical turnaround time for this specialized immunological assay is 24 to 48 hours from the time of sample collection. Once the clinical report is verified by a consultant pathologist, patients receive an automated SMS notification containing a direct link to download their electronic report. Reports can also be accessed securely through the official Chughtai Lab website or the dedicated Chughtai Active mobile application. For patients who prefer physical copies, reports can be collected directly from any Chughtai Lab collection center or delivered to their home via our professional home delivery service.

Serum Anti-Tissue Transglutaminase IgG Findings Overview

The interpretation of Serum Anti-Tissue Transglutaminase IgG results requires careful correlation with the patient’s dietary history and overall clinical picture. The table below outlines the general diagnostic parameters and clinical interpretations:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-tTG IgG Antibody Level	Negative (< 10 U/mL)	Positive (≥ 10 U/mL) indicating active celiac disease, gluten-sensitive enteropathy, or dermatitis herpetiformis.
Total Serum IgA Level	Normal for age (e.g., 70–400 mg/dL for adults)	Decreased (< 70 mg/dL) or undetectable, confirming selective IgA deficiency and validating the use of IgG-based testing.
Small Intestinal Mucosa (Indirect)	Intact villous architecture, normal absorption capacity	Villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis (suggested by high antibody titers).
Dietary Compliance Status	Undetectable/low antibody levels on a strict GFD	Elevated antibody levels indicating ongoing gluten exposure or dietary non-compliance.
Clinical Symptoms Correlation	Absence of gastrointestinal or systemic symptoms	Resolution of chronic diarrhea, anemia, and weight loss correlating with declining antibody titers.
Pediatric Growth Parameters	Normal growth velocity and developmental milestones	Growth failure, short stature, or delayed puberty associated with high autoantibody levels and malabsorption.
Extraintestinal Manifestations	Healthy skin, normal bone density, normal liver enzymes	Dermatitis herpetiformis, osteopenia, or elevated transaminases associated with active systemic autoimmune response.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum Anti-Tissue Transglutaminase IgG?

• Experienced healthcare professionals who oversee every step of the testing process, from sample collection to final pathological verification.
• Patient-focused care designed to ensure a comfortable, stress-free experience at all our collection centers.
• Quality diagnostic services backed by rigorous internal and external quality control programs to guarantee clinical accuracy.
• Professional reporting with clear, quantitative values and clinical reference ranges to assist your physician in making informed decisions.
• Modern diagnostic approach utilizing fully automated, state-of-the-art ELISA and CLIA platforms.
• Comfortable environment in all our centers, maintained to the highest standards of hygiene and patient safety.
• Convenient location network spanning across major cities and remote areas of Pakistan, ensuring easy accessibility.
• Commitment to accurate diagnosis through continuous investment in advanced medical technologies and staff training.